BIO-RAD LABORATORIES, INC. — Director's Dealing 2014

Nov 13, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2014-11-12

Reporting Person: TSINGOS CHRISTINE A (EVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-12	Bio-Rad A Common Stock	M	1000	$62.47	Acquired	6286.0979	Direct
2014-11-12	Bio-Rad A Common Stock	M	3000	$75.32	Acquired	9286.0979	Direct
2014-11-12	Bio-Rad A Common Stock	M	3000	$74.27	Acquired	12286.0979	Direct
2014-11-12	Bio-Rad A Common Stock	S	7000	$112.22	Disposed	5286.0979	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-12	Non-Qualified Stock Option (right to buy)	$62.47	M	1000	Disposed	2016-04-03	Bio-Rad A Common Stock (1000)	Direct
2014-11-12	Non-Qualified Stock Option (right to buy)	$75.32	M	3000	Disposed	2017-08-01	Bio-Rad A Common Stock (3000)	Direct
2014-11-12	Non-Qualified Stock Option (right to buy)	$74.27	M	3000	Disposed	2019-06-10	Bio-Rad A Common Stock (3000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.00 to $112.45, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The option vested in five equal annual installments beginning on April 3, 2007.

F3: The option vested in five equal annual installments beginning on August 1, 2008.

F4: The option vested in five equal annual installments beginning on June 10, 2010.